PL3058958T3 - Kompozycja anidulafunginy - Google Patents

Kompozycja anidulafunginy

Info

Publication number
PL3058958T3
PL3058958T3 PL16156402T PL16156402T PL3058958T3 PL 3058958 T3 PL3058958 T3 PL 3058958T3 PL 16156402 T PL16156402 T PL 16156402T PL 16156402 T PL16156402 T PL 16156402T PL 3058958 T3 PL3058958 T3 PL 3058958T3
Authority
PL
Poland
Prior art keywords
anidulafungin
composition
anidulafungin composition
Prior art date
Application number
PL16156402T
Other languages
English (en)
Inventor
Karlheinz Doser
Marinus Van Boven
Yuan JIANDONG
Original Assignee
Selectchemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55404612&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3058958(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Selectchemie Ag filed Critical Selectchemie Ag
Publication of PL3058958T3 publication Critical patent/PL3058958T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
PL16156402T 2015-02-23 2016-02-18 Kompozycja anidulafunginy PL3058958T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102015203222 2015-02-23
EP16156402.6A EP3058958B1 (en) 2015-02-23 2016-02-18 Anidulafungin composition

Publications (1)

Publication Number Publication Date
PL3058958T3 true PL3058958T3 (pl) 2019-02-28

Family

ID=55404612

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16156402T PL3058958T3 (pl) 2015-02-23 2016-02-18 Kompozycja anidulafunginy

Country Status (3)

Country Link
EP (1) EP3058958B1 (pl)
ES (1) ES2694561T3 (pl)
PL (1) PL3058958T3 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017037232A1 (en) * 2015-09-02 2017-03-09 Xellia Pharmaceuticals Aps Anidulafungin formulations
CN106729723A (zh) * 2016-11-21 2017-05-31 青岛农业大学 一种含匹莫苯丹的药物组合物及其制备方法
CN109481665B (zh) * 2018-12-05 2019-08-06 广州迈达康医药科技有限公司 一种注射用阿尼芬净复溶药剂及其制备方法
US12195755B2 (en) 2019-05-20 2025-01-14 Brown University Placental lipid bilayer for cell-free molecular interaction studies
US11273124B2 (en) 2019-05-23 2022-03-15 Brown University Antifungal nanoparticles for targeted treatment of fungal infections
US12509559B2 (en) 2019-10-28 2025-12-30 Brown University Bacterial beta-lactamase responsive hydrogels

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122315A (en) 1992-03-19 2002-03-10 Lilly Co Eli Cyclic peptides and antifungal pharmaceutical compositions containing them
AR006598A1 (es) 1996-04-19 1999-09-08 Merck Sharp & Dohme "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
ATE338059T1 (de) 1998-12-09 2006-09-15 Lilly Co Eli Reinigung von echinocandin cyclopeptiden
AU772633B2 (en) 1999-03-03 2004-05-06 Eli Lilly And Company Echinocandin/carbohydrate complexes
DK1582204T3 (da) 1999-03-03 2013-11-04 Lilly Co Eli Echinocandin-farmaceutiske formuleringer, der indeholder miceldannende overfladeaktive stoffer
TWI233805B (en) 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
TW200826957A (en) 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
US20090238867A1 (en) 2007-12-13 2009-09-24 Scott Jenkins Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
JP2011520889A (ja) 2008-05-15 2011-07-21 バクスター・インターナショナル・インコーポレイテッド 安定な医薬製剤
SI3677252T1 (sl) 2012-03-19 2024-02-29 Cidara Therapeutics, Inc. Sheme odmerjanja za spojine iz razreda ehinokandinov

Also Published As

Publication number Publication date
ES2694561T3 (es) 2018-12-21
EP3058958B1 (en) 2018-09-19
EP3058958A1 (en) 2016-08-24

Similar Documents

Publication Publication Date Title
GB201512030D0 (en) Composition
GB201506827D0 (en) Composition
GB201505527D0 (en) Composition
GB201521507D0 (en) Composition
GB201506830D0 (en) Composition
GB201506829D0 (en) Composition
GB201506825D0 (en) Composition
PT3344702T (pt) Composição
GB2545773B (en) Composition
PL3058958T3 (pl) Kompozycja anidulafunginy
GB201504665D0 (en) Composition
GB201522603D0 (en) Composition
GB201515639D0 (en) Composition
GB201504307D0 (en) Composition
GB201522681D0 (en) Composition
GB201519327D0 (en) Composition
GB201518348D0 (en) Composition
GB201514585D0 (en) Composition
GB201506828D0 (en) Composition
GB201505520D0 (en) Composition
GB2537648B (en) Composition
GB201511697D0 (en) Composition
GB201509044D0 (en) Composition
GB201508722D0 (en) Composition
GB201521384D0 (en) Composition